Overexpression of GST, particularly GSTP1-1, has been linked to innate and acquired resistance to anticancer drugs [133], indicating that cancer cells utilize the GSH-binding activity of GST to evade the effects of these drugs. This evidence concerns the gene GSTP1 and cancer.